Answers are grounded in this paper and cite their sources.
The risk of local relapse was very low in our series of nipple-sparing mastectomies performed for DCIS or invasive cancer. Nipple-sparing mastectomy in the risk-reducing and breast cancer-treatment settings may be feasible in selected patients and should be the subject of additional prospective clinical trials.
No takes yet. Share an insight, caveat, or question.
Sacchini et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: